Drug intelligence / Profile preview

sdBCMA2.28z CAR-T

Development stage
Preclinical
Lead developer
BC Cancer Research Institute
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

sdBCMA2.28z CAR-T is a preclinical chimeric antigen receptor (CAR) T-cell therapy designed to target B-cell maturation antigen (BCMA). It incorporates a dual human/mouse species-reactive single-domain antibody (sdAb) binder, cloned from immunized llamas, linked to CD28 costimulatory and CD3z signaling domains. This dual-reactivity allows the CAR-T cells to be evaluated in immunocompetent syngeneic mouse models (such as the Vk*MYC model of multiple myeloma) to study host-tumor-effector cell interactions and microenvironment changes, mimicking clinical settings of multiple myeloma.

Other names
sdBCMA2.28z CAR-T cellssdBCMA-2.28z CAR-T cellssdBCMA 2.28z CAR-T cells
02

Targets

TNFSF13 (APRIL)BAFF (Tumor necrosis factor ligand superfamily member 13B)BCMA (B-cell maturation antigen)CD28 (Cluster of Differentiation 28)CD3 (T-cell surface glycoprotein CD3)

Beyond the preview

Go deeper on sdBCMA2.28z CAR-T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sdBCMA2.28z CAR-T.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call